Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed to Present at the Jefferies 2017 London Healthcare Conference

November 15, 2017

Affimed Reports Financial Results for Third Quarter 2017

November 7, 2017

Affimed to Present at the 26th Annual Credit Suisse Healthcare Conference

November 2, 2017

Affimed to Present Clinical and Preclinical Data on Immune Cell Engagers at ASH

November 2, 2017

Affimed Announces Third Quarter 2017 Financial Results and Corporate Update Conference Call

October 30, 2017

Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology

September 22, 2017

Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer

September 13, 2017

Affimed to Present at the 2017 Wells Fargo Healthcare Conference – Boston

September 4, 2017

Affimed Reports Financial Results for Second Quarter 2017

August 1, 2017

Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call

July 25, 2017

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27

Events

All
Scientific
Investors

28Mar

Innate Killer Summit

March 28 - 30, 2023 (San Diego, USA)

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2023 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact